CVS Health Valuation

CVS -- USA Stock  

USD 60.54  1.51  2.43%

CVS Health shows prevailing Real Value of $72.3335 per share. The current price of the firm is $60.54. At this time the firm appears to be undervalued. This module approximates value of CVS Health from analyzing the firm fundamentals such as Profit Margin of 1.91% and Return On Equity of 8.90% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.
Undervalued
August 23, 2019
60.54
Market Value
72.33
Real Value
77.40
Upside
CVS Health is very steady asset. Calculation of real value of CVS Health is based on 2 months time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
CVS Health Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

CVS Health Market Cap

CVS Health Corporation is rated fourth in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 584.27 Billion. CVS Health retains roughly 79.84 Billion in market capitalization claiming about 14% of equities under Health Care Plans industry.
Capitalization  Workforce  Revenue  Total debt  Valuation
Horizon     30 Days    Login   to change
CVS Health Corporation is rated below average in last dividend paid category among related companies. It is rated below average in price to sales category among related companies fabricating about  0.18  of Price to Sales per Last Dividend Paid. The ratio of Last Dividend Paid to Price to Sales for CVS Health Corporation is roughly  5.71 

Valuation Basics

CVS Health Enterprise Value Fundamentals

Quick Ratio0.54
Revenue Growth35.20%
Payout Ratio56.34%
Enterprise Value To Ebitda10.94
Enterprise Value To Revenue0.72
Check also Trending Equities. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Search macroaxis.com